The antibody, p16INK4a, is a cyclin-dependent kinase inhibitor that plays a key role in cell cycle regulation and differentiation. Strong overexpression of p16 in cancer tissues is closely linked to expression of human papillomavirus (HPV) E7 oncoprotein.